JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity
Journal of Allergy and Clinical Immunology · 2025-02 · 155 (2) · 357-367
DOI: 10.1016/j.jaci.2024.09.020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-02. Verfasst von Simran Samra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, Canada; Experimental Medicine Program,…. Hauptthemen laut MEDLINE: Signal Transduction, Janus Kinases, STAT Transcription Factors, Inflammation. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Genome British Columbia, National Institute of Allergy and Infectious Diseases, Canadian Institutes of Health Research.
Abstract (Originalsprache)
The Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling cascade is an evolutionarily conserved signal transduction pathway that regulates many vital cellular processes, including immune function and hematopoiesis. Human genetic variants that disrupt JAK-STAT signaling are being found to cause a rapidly increasing number of diseases, including both germline-encoded inborn errors of immunity (IEI) and acquired somatic variants, causing a so-called phenocopy of the IEI. Multiple genetic mechanisms are responsible for this growing group of JAK-STAT diseases including loss-of-function, gain-of-function, and dominant negative effects. In this review, we discuss the clinical presentation and pathogenesis of all currently described JAK-STAT defects, as well as provide an overview of the guiding principles to consider in diagnosing and treating these conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, Canada; Experimental Medicine Program, Department of Medicine, The University of British Columbia, Vancouver…
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
- Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, Canada. Electronic address: sturvey@cw.bc.ca.
Förderung
- Genome British Columbia
- National Institute of Allergy and Infectious Diseases
- Canadian Institutes of Health Research
Zitieren
APA
Samra, S., Bergerson, J. R. E., Freeman, A. F., & Turvey, S. E. (2025). JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity. Journal of Allergy and Clinical Immunology, 155(2), 357-367. https://doi.org/10.1016/j.jaci.2024.09.020
Vancouver
Samra S, Bergerson JRE, Freeman AF, Turvey SE. JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity. Journal of Allergy and Clinical Immunology. 2025;155(2):357-367. doi:10.1016/j.jaci.2024.09.020
BibTeX
@article{Samra2025,
author = {Samra, Simran and Bergerson, Jenna R E and Freeman, Alexandra F and Turvey, Stuart E},
title = {JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
volume = {155},
number = {2},
pages = {357--367},
doi = {10.1016/j.jaci.2024.09.020}
}
EUVIMED